Healthcare & Life Sciences
HDAX Therapeutics
Toronto, Canadahdaxtx.com
HDAX Therapeutics is a Healthcare & Life Sciences startup based in Toronto, Canada, most recent round Series C+, 3 tracked investors.
possibledeadseries-c-plus
series-c-plus
Stage
3
Investors
About HDAX Therapeutics
HDAX Therapeutics is a company headquartered in Toronto, Canada. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
HDAX Therapeutics develops potent and selective small molecule inhibitors targeting HDAC6 using a proprietary two-site binding mechanism, aiming to treat neurological and cardiovascular diseases.
Explore HDAX Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.